Veterinary Medicines

Milquantel 12.5mg/125.0mg Tablets for Dogs

Authorised
  • Praziquantel
  • Milbemycin oxime
Download as PDF

Product identification

Medicine name:
Milquantel 12.5mg/125.0mg Tablets for Dogs
Milquantel 12,5 mg/125 mg compresse per cani che pesano almeno 5 kg
Active substance:
  • Praziquantel
  • Milbemycin oxime
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    125.00
    milligram(s)
    /
    1.00
    Tablet
  • Milbemycin oxime
    12.50
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • Blister packs consisting of cold formed OPA_Al_PVC foil and aluminium foil. Box with 1 blister of 4 tablets
  • Blister packs consisting of cold formed OPA_Al_PVC foil and aluminium foil. Box with 1 blister of 2 tablets
  • Blister packs consisting of cold formed OPA_Al_PVC foil and aluminium foil. Box with 12 blisters of 4 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 105104
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0259/002
Concerned member states:
  • France
  • Italy
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 4/04/2024
Download
Italian (PDF)
Published on: 14/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."